Home/Kelso Pharma/Andrew McLean

AM

Andrew McLean

Chief Corporate Development Officer & General Counsel

Therapeutic Areas

Oncology Rare Disease

Leadership Team at Kelso Pharma

Dr Tom Stratford

Dr. Bee Koen Low

Gordon Cameron OBE

Non-Executive Chairman

Managing Director

Director of Corporate Development

View full Kelso Pharma profile